EMEA-002079-PIP01-16

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA that is covalently linked to a ligand containing three N-acetylgalactosamine residues (ALN-GO1)

Decision numberP/0373/2017
PIP numberEMEA-002079-PIP01-16
Pharmaceutical form(s)Solution for injection
Condition(s)/indication(s)

Treatment of hyperoxaluria

Route(s) of administrationSubcutaneous use
PIP applicant

Alnylam UK Limited
Tel. +1  8663300326
E-mail: clinicaltrials@alnylam.com

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision